Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Laboratory tools for tuberculosis control in a setting with a high burden of HIV/AIDS.

Reis AJ, Diniz JLCG, Silva ABS, Silveira J, Basso R, Vieira R, von Groll A, Ramis IB, da Silva PEA.

J Med Microbiol. 2019 Oct 9. doi: 10.1099/jmm.0.001089. [Epub ahead of print]

PMID:
31596198
2.

The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin.

Vianna JS, Machado D, Ramis IB, Silva FP, Bierhals DV, Abril MA, von Groll A, Ramos DF, Lourenço MCS, Viveiros M, da Silva PEA.

Antibiotics (Basel). 2019 Sep 18;8(3). pii: E153. doi: 10.3390/antibiotics8030153.

3.

Tuberculosis caused by Mycobacterium pinnipedii in a wild South American sea lion Otaria flavescens stranded in southern Brazil.

Martins Melo A, Silva Filho RPD, von Groll A, Reis AJ, Diniz J, Perdigão J, Portugal I, da Silva PEA, Borelli Grecco F, Orzechowski Xavier M.

Dis Aquat Organ. 2019 Mar 28;133(3):189-194. doi: 10.3354/dao03342.

PMID:
31187733
4.

Mycobacterium avium: an overview.

Busatto C, Vianna JS, da Silva LV Junior, Ramis IB, da Silva PEA.

Tuberculosis (Edinb). 2019 Jan;114:127-134. doi: 10.1016/j.tube.2018.12.004. Epub 2019 Jan 4. Review.

PMID:
30711152
5.

Molecular modelling and competitive inhibition of a Mycobacterium tuberculosis multidrug-resistance efflux pump.

Scaini JLR, Camargo AD, Seus VR, von Groll A, Werhli AV, da Silva PEA, Machado KDS.

J Mol Graph Model. 2019 Mar;87:98-108. doi: 10.1016/j.jmgm.2018.11.016. Epub 2018 Dec 3.

PMID:
30529931
6.

Alternative Pharmaceutical Formulation for Oral Administration of Rifampicin.

Halicki PCB, Hädrich G, Boschero R, Ferreira LA, von Groll A, da Silva PEA, Dora CL, Ramos DF.

Assay Drug Dev Technol. 2018 Oct 16. doi: 10.1089/adt.2018.874. [Epub ahead of print]

PMID:
30325673
7.

Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases of Escherichia coli and Klebsiella spp. Isolates from Urinary Tract Infections in Southern Brazil.

Pereira JL, Volcão LM, Klafke GB, Vieira RS, Gonçalves CV, Ramis IB, da Silva PEA, von Groll A.

Microb Drug Resist. 2019 Mar;25(2):173-181. doi: 10.1089/mdr.2018.0046. Epub 2018 Aug 22.

PMID:
30133334
8.

Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin.

Corrêa Barros LP, Del Rio KP, Carvalho TDSC, Pinto MDCFR, de Moura KCG, Halicki PCB, Ramos DF, da Silva PEA.

Tuberculosis (Edinb). 2018 Jul;111:198-201. doi: 10.1016/j.tube.2018.06.015. Epub 2018 Jul 3.

PMID:
30029908
9.

Antimicrobial and Efflux Inhibitor Activity of Usnic Acid Against Mycobacterium abscessus.

Ramis IB, Vianna JS, Reis AJ, von Groll A, Ramos DF, Viveiros M, da Silva PEA.

Planta Med. 2018 Nov;84(17):1265-1270. doi: 10.1055/a-0639-5412. Epub 2018 Jun 18.

PMID:
29913527
10.

Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment.

Halicki PCB, Ferreira LA, De Moura KCG, Carneiro PF, Del Rio KP, Carvalho TDSC, Pinto MDCFR, da Silva PEA, Ramos DF.

Front Microbiol. 2018 Apr 9;9:673. doi: 10.3389/fmicb.2018.00673. eCollection 2018.

11.

High frequency of aac(6')-Ib-cr gene associated with double mutations in gyrA and parC in Escherichia coli isolates from patients with urinary tract infections.

Volcão LM, Lacava JP, Gewehr MF, Leal VL, Ramis IB, Ramos DF, Gonçalves CV, Possuelo LG, Minarini LAR, da Silva PEA, von Groll A.

J Glob Antimicrob Resist. 2018 Jun;13:180-183. doi: 10.1016/j.jgar.2017.12.013. Epub 2018 Jan 4.

PMID:
29307860
12.

Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus.

Ramis IB, Figueiredo R, Ramos DF, Halicki PCB, von Groll A, Viveiros M, do Ceu Costa M, da Silva PEA.

Med Chem. 2018;14(4):394-399. doi: 10.2174/1573406414666171204102633.

PMID:
29205119
13.

Multiplex detection of extensively drug resistant tuberculosis using binary deoxyribozyme sensors.

Bengtson HN, Homolka S, Niemann S, Reis AJ, da Silva PE, Gerasimova YV, Kolpashchikov DM, Rohde KH.

Biosens Bioelectron. 2017 Aug 15;94:176-183. doi: 10.1016/j.bios.2017.02.051. Epub 2017 Mar 1.

14.

An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria.

Costa SS, Lopes E, Azzali E, Machado D, Coelho T, da Silva PE, Viveiros M, Pieroni M, Couto I.

Assay Drug Dev Technol. 2016 Nov;14(9):524-534.

PMID:
27845849
15.

Toxocara canis: anthelmintic activity of quinone derivatives in murine toxocarosis.

Mata-Santos T, Mata-Santos HA, Carneiro PF, De Moura KC, Fenalti JM, Klafke GB, Cruz LA, Martins LH, Pinto NF, Pinto MC, Berne ME, Da Silva PE, Scaini CJ.

Parasitology. 2016 Apr;143(4):507-17. doi: 10.1017/S0031182016000068. Epub 2016 Feb 18.

PMID:
26887285
16.

Toxocara canis: Larvicidal activity of fatty acid amides.

Mata-Santos T, D'Oca CDRM, Mata-Santos HA, Fenalti J, Pinto N, Coelho T, Berne ME, da Silva PEA, D'Oca MGM, Scaini CJ.

Bioorg Med Chem Lett. 2016 Feb 1;26(3):739-741. doi: 10.1016/j.bmcl.2016.01.002. Epub 2016 Jan 5.

PMID:
26783180
17.

Evaluation of direct microplate nitrate reductase assay as a rapid method for the detection of multiple and extensively tuberculosis drug resistance.

Abilleira F, Brum C, von Groll A, da Silva PE.

Biomedica. 2015 Apr-Jun;35(2):285-91. doi: 10.1590/S0120-41572015000200017.

PMID:
26535551
18.

Relationship of interleukin-1B gene promoter region polymorphism with Helicobacter pylori infection and gastritis.

Ramis IB, Vianna JS, Halicki PC, Lara C, Tadiotto TF, da Silva Maciel JB, Gonçalves CV, von Groll A, Dellagostin OA, da Silva PE.

J Infect Dev Ctries. 2015 Sep 29;9(10):1108-16. doi: 10.3855/jidc.6123.

19.

ANTHELMINTIC ACTIVITY OF LAPACHOL, β-LAPACHONE AND ITS DERIVATIVES AGAINST Toxocara canis LARVAE.

Mata-Santos T, Pinto NF, Mata-Santos HA, De Moura KG, Carneiro PF, Carvalho Tdos S, Del Rio KP, Pinto Mdo C, Martins LR, Fenalti JM, Da Silva PE, Scaini CJ.

Rev Inst Med Trop Sao Paulo. 2015 May-Jun;57(3):197-204. doi: 10.1590/S0036-46652015000300003.

20.

Detection of Helicobacter pylori CagA EPIYA in gastric biopsy specimens and its relation to gastric diseases.

Vianna JS, Ramis IB, Halicki PC, Gastal OL, Silva RA, Junior JS, Dos Santos DM, Chaves AL, Juliano CR, Jannke HA, da Silva LV Jr, Von Groll A, da Silva PE.

Diagn Microbiol Infect Dis. 2015 Oct;83(2):89-92. doi: 10.1016/j.diagmicrobio.2015.05.017. Epub 2015 Jun 10.

PMID:
26144892
21.

Polymorphisms of the IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in patients infected with Helicobacter pylori.

Ramis IB, Vianna JS, Gonçalves CV, von Groll A, Dellagostin OA, da Silva PEA.

J Microbiol Immunol Infect. 2017 Apr;50(2):153-159. doi: 10.1016/j.jmii.2015.03.002. Epub 2015 Mar 24.

22.

Antimicrobial susceptibility of rapidly growing mycobacteria using the rapid colorimetric method.

Ramis IB, Cnockaert M, von Groll A, Nogueira CL, Leão SC, Andre E, Simon A, Palomino JC, da Silva PE, Vandamme P, Martin A.

Eur J Clin Microbiol Infect Dis. 2015 Jul;34(7):1403-13. doi: 10.1007/s10096-015-2365-2. Epub 2015 Mar 29.

PMID:
25820290
23.

Antimycobacterial and cytotoxicity activity of microcystins.

Ramos DF, Matthiensen A, Colvara W, de Votto AP, Trindade GS, da Silva PE, Yunes JS.

J Venom Anim Toxins Incl Trop Dis. 2015 Mar 20;21:9. doi: 10.1186/s40409-015-0009-8. eCollection 2015.

24.

Molecular typing of Mycobacterium bovis isolated in the south of Brazil.

Ramos DF, Silva AB, Fagundes MQ, von Groll A, da Silva PE, Dellagostin OA.

Braz J Microbiol. 2014 Aug 29;45(2):657-60. eCollection 2014.

25.

Molecular typing of Mycobacterium bovis isolates: a review.

Ramos DF, Tavares L, da Silva PE, Dellagostin OA.

Braz J Microbiol. 2014 Aug 29;45(2):365-72. eCollection 2014. Review.

26.

Authors reply: cagE as a biomarker of the pathogenicity of Helicobacter pylori.

Ramis IB, Vianna JS, Silva Junior LV, Von Groll A, da Silva PE.

Rev Soc Bras Med Trop. 2014 May-Jun;47(3):404. No abstract available.

27.

Transmammary infection in BALB/c mice with chronic toxocariasis.

de Souza Aguiar P, Furtado RD, de Avila LF, de Lima Telmo P, Martins LH, Berne ME, da Silva PE, Scaini CJ.

Parasitol Int. 2015 Apr;64(2):145-7. doi: 10.1016/j.parint.2014.04.010. Epub 2014 May 13.

PMID:
24837181
28.

Mycobacterium tuberculosis belonging to family LAM and sublineage RD(Rio): common strains in Southern Brazil for over 10 years.

Soares RO, de Macedo MB, von Groll A, da Silva PE.

Braz J Microbiol. 2014 Mar 10;44(4):1251-5. eCollection 2013 Dec.

29.

Medicinal plants from open-air markets in the State of Rio de Janeiro, Brazil as a potential source of new antimycobacterial agents.

Leitão F, Leitão SG, de Almeida MZ, Cantos J, Coelho T, da Silva PE.

J Ethnopharmacol. 2013 Sep 16;149(2):513-21. doi: 10.1016/j.jep.2013.07.009. Epub 2013 Jul 18.

30.

Triterpenes and the antimycobacterial activity of Duroia macrophylla Huber (Rubiaceae).

Martins D, Carrion LL, Ramos DF, Salomé KS, da Silva PE, Barison A, Nunez CV.

Biomed Res Int. 2013;2013:605831. doi: 10.1155/2013/605831. Epub 2013 Feb 12.

31.

Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes.

Spies FS, von Groll A, Ribeiro AW, Ramos DF, Ribeiro MO, Dalla Costa ER, Martin A, Palomino JC, Rossetti ML, Zaha A, da Silva PE.

Tuberculosis (Edinb). 2013 Mar;93(2):150-4. doi: 10.1016/j.tube.2012.11.004. Epub 2012 Dec 29.

PMID:
23276692
32.

Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma.

Zhang L, Prietsch SO, Mendes AP, Von Groll A, Rocha GP, Carrion L, Da Silva PE.

Respirology. 2013 Feb;18(2):272-7. doi: 10.1111/j.1440-1843.2012.02280.x.

PMID:
23039314
33.

1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.

Moura KC, Carneiro PF, Pinto Mdo C, da Silva JA, Malta VR, de Simone CA, Dias GG, Jardim GA, Cantos J, Coelho TS, da Silva PE, da Silva EN Jr.

Bioorg Med Chem. 2012 Nov 1;20(21):6482-8. doi: 10.1016/j.bmc.2012.08.041. Epub 2012 Aug 31.

34.

Improving tuberculosis control through the partnership between university and the health system.

Valença MS, da Rocha JZ, Ramis IB, Carrion LL, Madruga C, de Macedo MB, Scaini CJ, von Groll A, da Silva PE.

Rev Soc Bras Med Trop. 2012 Jul-Aug;45(4):491-5. Epub 2012 Jul 5.

35.

Nitrate reductase assay using sodium nitrate for rapid detection of multidrug resistant tuberculosis.

Macedo MB, Groll AV, Fissette K, Palomino JC, da Silva PE, Martin A.

Braz J Microbiol. 2012 Jul;43(3):981-3. doi: 10.1590/S1517-838220120003000019. Epub 2012 Jun 1.

36.

Evaluation of diagnostic methods for the detection of Helicobacter pylori in gastric biopsy specimens of dyspeptic patients.

Ramis IB, de Moraes EP, Fernandes MS, Mendoza-Sassi R, Rodrigues O, Juliano CR, Scaini CJ, da Silva PE.

Braz J Microbiol. 2012 Jul;43(3):903-8. doi: 10.1590/S1517-83822012000300008. Epub 2012 Jun 1.

37.

Histological and immunohistochemical analyses of the chronology of healing process after immediate tooth replantation in incisor rat teeth.

Panzarini SR, Okamoto R, Poi WR, Sonoda CK, Pedrini D, da Silva PE, Saito CT, Marão HF, Sedlacek P.

Dent Traumatol. 2013 Feb;29(1):15-22. doi: 10.1111/j.1600-9657.2012.01127.x. Epub 2012 Mar 13.

PMID:
22413942
38.

Saccharomyces boulardii reduces infection intensity of mice with toxocariasis.

de Avila LF, Conceição FR, Telmo Pde L, Dutra GF, de los Santos DG, Martins LH, Berne ME, da Silva PE, Scaini CJ.

Vet Parasitol. 2012 Jun 8;187(1-2):337-40. doi: 10.1016/j.vetpar.2012.01.002. Epub 2012 Jan 8.

PMID:
22305116
39.

In vitro anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene) isonicotinohydrazide derivatives against isoniazid-resistant strains.

Coelho TS, Cantos JB, Bispo ML, Gonçalves RS, Lima CH, da Silva PE, Souza MV.

Infect Dis Rep. 2012 Feb 6;4(1):e13. doi: 10.4081/idr.2012.e13. eCollection 2012 Jan 2. Review.

40.

Evaluation of the immunosuppressive effect of cyclophosphamide and dexamethasone in mice with visceral toxocariasis.

da Costa de Avila LF, da Fonseca JS, Dutra GF, de Lima Telmo P, Silva AM, Berne ME, da Silva PE, Conceição FR, Scaini CJ.

Parasitol Res. 2012 Jan;110(1):443-7. doi: 10.1007/s00436-011-2510-5. Epub 2011 Jul 12.

PMID:
21748353
41.

Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis.

da Silva PE, Von Groll A, Martin A, Palomino JC.

FEMS Immunol Med Microbiol. 2011 Oct;63(1):1-9. doi: 10.1111/j.1574-695X.2011.00831.x. Epub 2011 Jul 4. Review.

42.

Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene.

Spies FS, Ribeiro AW, Ramos DF, Ribeiro MO, Martin A, Palomino JC, Rossetti ML, da Silva PE, Zaha A.

J Clin Microbiol. 2011 Jul;49(7):2625-30. doi: 10.1128/JCM.00168-11. Epub 2011 May 18.

43.

Molecular Basis of pathogenicity in Helicobacter pylori clinical isolates.

Ramis IB, Fonseca TL, de Moraes EP, Fernandes MS, Mendoza-Sassi R, Rodrigues O, Juliano CR, Scaini CJ, da Silva PE.

J Clin Microbiol. 2010 Oct;48(10):3776-8. doi: 10.1128/JCM.00472-10. Epub 2010 Aug 4.

44.

Fitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotype.

von Groll A, Martin A, Stehr M, Singh M, Portaels F, da Silva PE, Palomino JC.

PLoS One. 2010 Apr 16;5(4):e10191. doi: 10.1371/journal.pone.0010191.

45.

Growth kinetics of Mycobacterium tuberculosis measured by quantitative resazurin reduction assay: a tool for fitness studies.

von Groll A, Martin A, Portaels F, da Silva PE, Palomino JC.

Braz J Microbiol. 2010 Apr;41(2):300-3. doi: 10.1590/S1517-83822010000200006. Epub 2010 Jun 1.

46.

Fitness study of the RDRio lineage and Latin American-Mediterranean family of Mycobacterium tuberculosis in the city of Rio Grande, Brazil.

Von Groll A, Martin A, Felix C, Prata PF, Honscha G, Portaels F, Vandame P, da Silva PE, Palomino JC.

FEMS Immunol Med Microbiol. 2010 Feb;58(1):119-27. doi: 10.1111/j.1574-695X.2009.00611.x. Epub 2009 Sep 17.

47.

Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.

Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PE, Fonseca Lde S, Ho JL, Kritski AL, Rossetti ML.

BMC Microbiol. 2009 Feb 19;9:39. doi: 10.1186/1471-2180-9-39.

48.

Treatment with a growth factor-protein mixture inhibits formation of mineralized nodules in osteogenic cell cultures grown on titanium.

de Oliva MA, Maximiano WM, de Castro LM, da Silva PE Jr, Fernandes RR, Ciancaglini P, Beloti MM, Nanci A, Rosa AL, de Oliveira PT.

J Histochem Cytochem. 2009 Mar;57(3):265-76. doi: 10.1369/jhc.2008.952713. Epub 2008 Nov 24.

49.

Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism.

Spies FS, da Silva PE, Ribeiro MO, Rossetti ML, Zaha A.

Antimicrob Agents Chemother. 2008 Aug;52(8):2947-9. doi: 10.1128/AAC.01570-07. Epub 2008 Jun 9.

50.

The laboratory as a tool to qualify tuberculosis diagnosis.

Honscha G, Von Groll A, Valença M, Ramos DF, Sanchotene K, Scaini CJ, Ribeiro MO, da Silva PE.

Int J Tuberc Lung Dis. 2008 Feb;12(2):218-20.

PMID:
18230257

Supplemental Content

Loading ...
Support Center